Minardo John - 15 Aug 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Legal Officer
Signature
/s/ Ronald Silver, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Aug 2022
Net transactions value
-$86,274
Form type
4
Filing time
17 Aug 2022, 16:05:14 UTC
Previous filing
04 Mar 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale $86,274 -7,330 -5% $11.77 140,435 15 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.